Uridine 5'-triphosphate Terminated Phase 2 Trials for Interstitial Lung Diseases (ILD)

Indications	Status	Purpose	Phase
DBCOND0125572 (Interstitial Lung Diseases (ILD))	Terminated	Not Available	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01381666	Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)	Sodium chloride (DB09153) Uridine 5'-triphosphate (DB04005)